Abpro Holdings, Inc.(ABPO)
Biotechnology
Antibody Engineering (mAbs, bispecifics, ADCs)
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-08-04 | Suk Jin Wook (Miles) CEO and Chairman | Purchase | +72,035 | +9.48%831,962 | $0.28 | $20,170 | View SEC filing | |
| 2025-05-19 | Suk Jin Wook (Miles) CEO and Chairman | Purchase | +16,200 | +2.18%759,927 | $0.26 | $4,212 | View SEC filing | |
| 2025-05-01 | Suk Jin Wook (Miles) CEO and Chairman | Purchase | +4,325 | +0.58%743,727 | $0.25 | $1,081 | View SEC filing | |
| 2025-04-25 | Suk Jin Wook (Miles) CEO and Chairman | Purchase | +34,002 | +4.82%739,402 | $0.33 | $11,113 | View SEC filing |
1-4 of 4